EyePoint Pharmaceuticals(DE:PV3B)
€0.250.00 (0.00%)
DE:PV3B
EyePoint Pharmaceuticals earnings date
€0.25
At close:0.00 (0.00%)
EyePoint Pharmaceuticals (PV3B) Q4 2018 Earnings Report
1 Followers
DE:PV3B Q4 2018 EPS Results
- Actual EPS
- -EUR 5.65
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 1.46
DE:PV3B Q4 2018 Revenue Results
- Actual Revenue
- EUR 651.78K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2018
- Date
- 09/12/2018
- Time
- TBA
- Conference Call
- Wednesday, September 12, 2018
DE:PV3B Upcoming Earnings
EyePoint Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q4 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:PV3B Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.63- | -0.74 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.85-0.98 | -0.77 | -25.88% (-0.20) | |
| Aug 05, 2026 | 2026 (Q2) | -0.90-0.99 | -0.77 | -28.24% (-0.22) | |
| May 06, 2026 | 2026 (Q1) | -0.73-0.90 | -0.59 | -52.31% (-0.31) | |
| Mar 04, 2026 | 2025 (Q4) | -0.68-0.74 | -0.58 | -26.56% (-0.15) | |
| Nov 05, 2025 | 2025 (Q3) | -0.70-0.77 | -0.49 | -57.41% (-0.28) | |
| Aug 06, 2025 | 2025 (Q2) | -0.75-0.77 | -0.53 | -46.55% (-0.25) | |
| May 07, 2025 | 2025 (Q1) | -0.61-0.59 | -0.5 | -18.18% (-0.09) | |
| Mar 05, 2025 | 2024 (Q4) | -0.44-0.58 | -0.3 | -93.94% (-0.28) | |
| Nov 07, 2024 | 2024 (Q3) | -0.50-0.49 | -0.3 | -63.64% (-0.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

